The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement

BJOG: An International Journal of Obstetrics & Gynaecology

Volumn 99, Issue 10, 1992, Pages 821-828

  FALKEBORN, MARGARETA ^a   PERSSON, INGEMAR ^b   ADAMI, HANS‐OLOV ^c   BERGSTRÖM, REINHOLD ^d   EAKER, ELAINE ^e   LITHELL, HANS ^d   MOHSEN, RAWYA ^d   NAESSEN, TORD ^d  

^a Department of Geriatrics ^*

^b DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

^c University Hospital ^*

^d UPPSALA UNIVERSITY   (Sweden)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; LYNESTRENOL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ADULT; ARTICLE; FEMALE; HEART INFARCTION; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; DRUG COMBINATIONS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGESTINS; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN;

EID: 0026738480     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1992.tb14414.x     Document Type: Article

References (42)

1. Use of replacement estrogcns and Ihe risk of myocardial infarction
2. Estrogen and coronary heart disease in women
3. Risk fac‐tors for breast and endomctrial cancer in a cohort of women treated with menopausal estrogen
4. The risk of breast cancer after estrogen and estrogen‐progestin replacement
5. A meta‐analysis of physical activity in the prevention of coronary heart disease
6. Multi‐plicative models and cohort analysis
7. Noncontraceptive estrogen use and cardiovascular disease
8. Cardiovascular mortality and noncontraceptive use of estrogen in women; results from the Lipid Research Clinics program fol‐low‐up study
9. Bias due to misclassification in the estimate of relative risk
10. Postmenopausal estrogen use and mortality
11. Epidemiology of osteoporosis and osteoporotic fractures
12. Coronary heart disease and its risk factors among women in the Framingham Study
13. The use of combined estrogen‐progestin replacement therapy
14. Estrogen replacement therapy and protection from acute myocardial infarction
15. Re‐evaluating the role of progestin therapy after the menopause
16. Effects of differ‐ent progestogens on lipoproteins during postmenopausal replacement therapy
17. Mortality in a cohort of long‐term users of hormone replacement therapy; an updated analysis
18. Noncontraceptive estrogen and nonfatal myocardial infarction
19. Myocardial infarction in women
20. Strat‐ified analyses
21. Risk factors for myocardial infarction in young women
22. Risks of estrogens and progestogens
23. Cardiovascular implicaüons of estrogen replacement therapy
24. Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic Problems
25. Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965–1985
26. Hormone replacement therapy and the risk for first hip fracture. A prospective, population‐based cohort study
27. Risk factors for acute myocardial infarction in Copenhagen. f; Hereditary, educational and socioeconomic factors
28. Practice and patterns of estrogen treatment in cli‐macteric women in a Swedish population. A descriptive epidemi‐ological study. Part 1
29. A cohort study on estrogen treatment and risk of cndometrial cancer; cvaulation of method and its applicability
30. Characteristics of estrogen‐treated women; a descriptive epidemiological study of a Swedish population. Part II
31. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms
32. Risk of endo‐metrial cancer after treatment with oestrogens alone or in con‐junction with progestogens
33. Non‐contraceptive estrogens and mortality; long‐term follow‐up of women in the Walnut Creek study
34. Estrogen replacement therapy and coronary heart disease; A quantitative assessment of the epi‐demiologic evidence
35. A prospcctive study of postmenopau‐sal estrogen therapy and coronary heart disease
36. The usc of hormonal replacement therapy and the risk of stroke and myocardial infarction in women
37. Postmenopausal oestrogen and cardio‐protection
38. Potency of different oestrogen preparations
39. Effects of estrogens and proges‐tins on the biochemistry and morphology of the postmenopausal endomclrium
40. Progestogen use in postmenopausal women. Consensus Conference
41. Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50; the Framingham Study
42. Reduction of cardiovascular disease‐related mortality among postmenopausal women who use hormones; evidence from a national cohort